202 related articles for article (PubMed ID: 21836500)
1. Diffuse large B-cell lymphoma with aberrant expression of the T-cell antigens CD2 and CD7.
Sangle NA; Agarwal AM; Smock KJ; Leavitt MO; Warnke R; Bahler D; Perkins SL
Appl Immunohistochem Mol Morphol; 2011 Dec; 19(6):579-83. PubMed ID: 21836500
[TBL] [Abstract][Full Text] [Related]
2. Aberrant expression of multiple T antigens: CD4, CD5, and CD8 on diffuse large B-cell lymphoma.
Sangle NA; Miles RR; Kelley TW; Perkins SL
Appl Immunohistochem Mol Morphol; 2014; 22(10):e45-8. PubMed ID: 24185124
[TBL] [Abstract][Full Text] [Related]
3. Clinical and prognostic significance of aberrant T-cell marker expression in 225 cases of de novo diffuse large B-cell lymphoma and 276 cases of other B-cell lymphomas.
Tsuyama N; Ennishi D; Yokoyama M; Baba S; Asaka R; Mishima Y; Terui Y; Hatake K; Takeuchi K
Oncotarget; 2017 May; 8(20):33487-33500. PubMed ID: 28380441
[TBL] [Abstract][Full Text] [Related]
4. Aberrant expression of T-cell-associated antigens on B-cell non-Hodgkin lymphomas.
Kaleem Z; White G; Zutter MM
Am J Clin Pathol; 2001 Mar; 115(3):396-403. PubMed ID: 11242796
[TBL] [Abstract][Full Text] [Related]
5. Incidence and clinical significance of aberrant T-cell marker expression on diffuse large B-cell lymphoma cells.
Suzuki Y; Yoshida T; Wang G; Aoki T; Katayama T; Miyamoto S; Miyazaki K; Iwabuchi K; Danbara M; Nakayama M; Horie R; Nakamine H; Sato Y; Nakamura N; Niitsu N
Acta Haematol; 2013; 130(4):230-7. PubMed ID: 23816831
[TBL] [Abstract][Full Text] [Related]
6. Reactive T cells by flow cytometry distinguish Hodgkin lymphomas from T cell/histiocyte-rich large B cell lymphoma.
Wu D; Thomas A; Fromm JR
Cytometry B Clin Cytom; 2016 Sep; 90(5):424-32. PubMed ID: 26084540
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus-negative diffuse large B cell lymphoma with aberrant expression of CD3 and other T cell-associated antigens: report of three cases with a review of the literature.
Wu B; Vallangeon B; Galeotti J; Sebastian S; Rehder C; Wang E
Ann Hematol; 2016 Oct; 95(10):1671-83. PubMed ID: 27431583
[TBL] [Abstract][Full Text] [Related]
8. [Loss of pan-T cell antigens CD2, CD3, CD5 and CD7 in Kikuchi's disease].
Wei XJ; Xie JL; Zhou XG; Zheng XD; Zheng YY; Jin Y; Zhu H; Zhang YN; Zhang SH; Chen GY
Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):815-9. PubMed ID: 22336206
[TBL] [Abstract][Full Text] [Related]
9. Richter's syndrome with aberrant CD2 and CD4 expression.
Barnhard S; Pai A; Chew HK; Song JY
J Clin Oncol; 2012 Sep; 30(26):e243-5. PubMed ID: 22649134
[No Abstract] [Full Text] [Related]
10. Large B-cell lymphoma with T-cell-rich background and nodules lacking follicular dendritic cell meshworks: description of an insufficiently recognized variant.
Treetipsatit J; Metcalf RA; Warnke RA; Natkunam Y
Hum Pathol; 2015 Jan; 46(1):74-83. PubMed ID: 25456392
[TBL] [Abstract][Full Text] [Related]
11. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
[TBL] [Abstract][Full Text] [Related]
12. T-cell associated antigen-positive B-cell lymphoma.
Inaba T; Shimazaki C; Sumikuma T; Nakagawa M
Leuk Lymphoma; 2001; 42(6):1161-71. PubMed ID: 11911397
[TBL] [Abstract][Full Text] [Related]
13. CD5+ T-cell/histiocyte-rich large B-cell lymphoma.
Chang CC; Bunyi-Teopengco E; Eshoa C; Chitambar CR; Kampalath B
Mod Pathol; 2002 Oct; 15(10):1051-7. PubMed ID: 12379751
[TBL] [Abstract][Full Text] [Related]
14. Composite primary breast diffuse large B-cell lymphoma and T lymphoblastic leukemia/lymphoma: report of a case and review of literature.
Guan C; Li J; Xu P; Ouyang J; Chen B
Int J Clin Exp Pathol; 2015; 8(8):9629-37. PubMed ID: 26464729
[TBL] [Abstract][Full Text] [Related]
15. Diffuse large B-cell lymphoma with coexpression of CD3 in a pediatric patient: a case report, review of the literature, and tissue microarray study.
Wallentine JC; Perkins SL; Tripp SR; Bruggman RD; Bayerl MG
J Pediatr Hematol Oncol; 2009 Feb; 31(2):124-7. PubMed ID: 19194198
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometry in the differential diagnosis of lymphocyte-rich thymoma from precursor T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma.
Li S; Juco J; Mann KP; Holden JT
Am J Clin Pathol; 2004 Feb; 121(2):268-74. PubMed ID: 14983942
[TBL] [Abstract][Full Text] [Related]
17. Expression of T-cell-associated antigens in B-cell non-Hodgkin's lymphoma.
Inaba T; Shimazaki C; Sumikuma T; Okano A; Hatsuse M; Okamoto A; Takahashi R; Ashihara E; Hibi S; Sudo Y; Yamagata N; Murakami S; Rin K; Fujita N; Yoshimura M; Nakagawa M
Br J Haematol; 2000 Jun; 109(3):592-9. PubMed ID: 10886209
[TBL] [Abstract][Full Text] [Related]
18. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
19. Immunophenotypic Characterization and Purification of Neoplastic Cells from Lymph Nodes Involved by T-Cell/Histiocyte-rich Large B-cell Lymphoma by Flow Cytometry and Flow Cytometric Cell Sorting.
Glynn E; Fromm JR
Cytometry B Clin Cytom; 2020 Jan; 98(1):88-98. PubMed ID: 31254446
[TBL] [Abstract][Full Text] [Related]
20. Normative data for flow cytometry immunophenotyping of benign lymph nodes sampled by surgical biopsy.
Scott GD; Atwater SK; Gratzinger DA
J Clin Pathol; 2018 Feb; 71(2):174-179. PubMed ID: 28916595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
